About TCR² Therapeutics Inc.

Website
Website
Employees
Employees
51-200 employees View all
Industry
Industry
biotechnology
Location
Location
Cambridge, Massachusetts, US
Description
Information
TCR² Therapeutics Inc. is a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer. TCR²’s proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC-T cells) specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). In preclinical studies, TRuC-T cells have demonstrated superior anti-tumor activity compared to chimeric antigen receptor T cells (CAR-T cells), while exhibiting lower levels of cytokine release.

TCR² Therapeutics Inc. Alternatives

Frequently Asked Questions about TCR² Therapeutics Inc.

What is TCR² Therapeutics Inc. email format?

The widely used TCR² Therapeutics Inc. email format is {first} (e.g. [email protected]) with 75% adoption across the company.


What is TCR² Therapeutics Inc. customer service number?

To contact TCR² Therapeutics Inc. customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more